Suramin Blocks Tumor Growth and Blood Vessel Formation
Author Information
Author(s): E. Pesentil, F. Sola, N. Mongelli, M. Grandil, F. Spreafico
Primary Institution: Farmitalia Carlo Erba Research Center
Hypothesis
Can suramin inhibit angiogenesis and tumor growth by blocking basic fibroblast growth factor (bFGF) activity?
Conclusion
Suramin effectively inhibits bFGF-induced angiogenesis and tumor growth in mice.
Supporting Evidence
- Suramin showed an inhibitory activity on bFGF-induced angiogenesis.
- Suramin reduced tumor growth in a murine model of reticulosarcoma.
- Exogenous administration of bFGF countered the effects of suramin.
Takeaway
Suramin is a drug that can stop tumors from growing by blocking the formation of new blood vessels that feed them.
Methodology
Mice were implanted with gelatin sponges containing bFGF, and suramin was administered to assess its effects on angiogenesis and tumor growth.
Limitations
The study did not evaluate the effects of other growth factors involved in angiogenesis.
Participant Demographics
Young adult female C3H/HeN and C57B1/6 mice, weighing 23-25 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website